Improvement of leukemia-free survival (ITS) and reduction of relapse incidence by allogeneic stem cell transplantation (SCT) in elderly patients (pts) with AML, irrespective of the FLT3-ITD and npm status except npm+/flt3(ITD)-

被引：0
|
作者：
Niederwieser, O.
Schueler, F.
Hegenbart, U.
Maschmeyer, G.
Fischer, T.
Junghanss, C.
Wolf, H.
Sayer, H. G.
Kreibich, U.
Doelken, G.
机构：
[1] Univ Leipzig, Dept Hematol Oncol & Hemostasis, D-04109 Leipzig, Germany
[2] Univ Hosp, Leipzig, Germany
[3] Amyloidosis Ctr, Heidelberg, Germany
[4] Potsdam Klinikum, Potsdam, Germany
[5] Univ Magdeburg, D-39106 Magdeburg, Germany
[6] Univ Rostock, D-18055 Rostock, Germany
[7] Univ Halle Wittenberg, D-06108 Halle, Germany
[8] Jena Uniklinikum, Jena, Germany
[9] Braun Krankenhaus, Zwickau, Germany
[10] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6505
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reduction of Relapse Incidence and improvement of Leukemia Free Survival by Allogeneic Stem Cell Transplantation in Patients with AML and Normal Karyotype Irrespective of the FLT3-ITD Status.
    Schueler, Frank
    Basara, Nadezda
    Maschmeyer, Georg
    Fischer, Thomas
    Herold, Michael
    Sayer, Herbert G.
    Wolf, Hans-Heinrich
    Kreibich, Ute
    Haehling, Detlev
    Doelken, Gottfried
    Junghanss, Christian
    Grobe, Norbert
    Krahl, Rainer
    Al-Ali, Haifa Kathrin
    Poenisch, Wolfram
    Niederwieser, Dietger
    BLOOD, 2009, 114 (22) : 644 - 644
  • [2] Response: Allogeneic stem cell transplantation and FLT3/ITD status in AML
    Gale, Rosemary E.
    Hills, Robert
    Wheatley, Keith
    Burnett, Alan K.
    Linch, David C.
    BLOOD, 2006, 108 (01) : 400 - 401
  • [3] Allogeneic stem cell transplantation reduces the relapse incidence in patients with AML and normal karyotype independently of the FLT3-ITD status
    Schueller, F.
    Maschmeyer, G.
    Fischer, T.
    Herold, M.
    Sayer, H. G.
    Wolf, H. -H.
    Kreibich, U.
    Haehling, D.
    Doelken, G.
    Junghanss, C.
    Grobe, N.
    Krahl, R.
    Lange, T.
    Al Ali, H. -K.
    Basara, N.
    Poenisch, W.
    Niederwieser, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S39 - S40
  • [4] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1
    Kim, Hyeoung-Joon
    Kim, TaeHyung
    Kook, Hoon
    Song, Ga-Young
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Kim, Mihee
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seung Hyun
    Kim, Mi Yeon
    Jung, Chul Won
    Jang, Jun-Ho
    Kim, Hee Je
    Moon, Joon Ho
    Sohn, Sang Kyun
    Won, Jong-Ho
    Park, Seong-Kyu
    Kim, Sung-Hyun
    Zhang, Zhaolei
    Ahn, Jae-Sook
    Kim, Dennis Dong Hwan
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 172 - 173
  • [5] Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation
    Iannotta, R.
    Celentano, M.
    Marotta, S.
    Pedata, C. M.
    Riccardi, C.
    Migliaccio, I.
    Viola, A.
    Muggianu, S. M.
    Falco, C.
    Bovenzi, D.
    Ferrara, F.
    Picardi, A.
    LEUKEMIA RESEARCH REPORTS, 2022, 18
  • [6] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey H.
    Viswabandya, Auro
    Kim, Dennis D.
    Thyagu, Santhosh
    Messner, Hans A.
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) : 368 - 374
  • [7] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey
    Viswabandya, Auro
    Kim, Dennis
    Thyagu, Santhosh
    Messner, Hans
    Michelis, Fotios
    BONE MARROW TRANSPLANTATION, 2018, 53 : 169 - 170
  • [8] Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML
    Meshinchi, Sohell
    Arceci, Robert J.
    Sanders, Jean E.
    Smith, Franklin O.
    Woods, William B.
    Radich, Jerald R.
    Alonzo, Todd A.
    BLOOD, 2006, 108 (01) : 400 - 400
  • [9] Measurable Residual Disease Status and FLT3 Inhibitor Therapy in Patients with FLT3-ITD Mutated AML Following Allogeneic Hematopoietic Cell Transplantation
    Liang, Emily C.
    Chen, Connie
    Lu, Rong
    Mannis, Gabriel N.
    Muffly, Lori
    BLOOD, 2021, 138
  • [10] Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
    Liang, Emily C.
    Chen, Connie
    Lu, Rong
    Mannis, Gabriel N.
    Muffly, Lori
    BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 3091 - 3093
12345